# PREVACT : Preventive REversal of Vitamine K Antagonist in Minor Craniocerebral Trauma

> **NCT01961804** · PHASE3 · TERMINATED · sponsor: **University Hospital, Angers** · enrollment: 202 (actual)

## Conditions studied

- Coagulation; Intravascular
- Craniocerebral Trauma
- Haemorrhage

## Interventions

- **DRUG:** Reversion

## Key facts

- **NCT ID:** NCT01961804
- **Lead sponsor:** University Hospital, Angers
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-03
- **Primary completion:** 2020-02-28
- **Final completion:** 2020-09-03
- **Target enrollment:** 202 (ACTUAL)
- **Last updated:** 2021-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01961804

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01961804, "PREVACT : Preventive REversal of Vitamine K Antagonist in Minor Craniocerebral Trauma". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01961804. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*